Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) EBT Margin (2016 - 2017)

Historic EBT Margin for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to 189.83%.

  • Bone Biologics' EBT Margin changed N/A to 189.83% in Q4 2017 from the same period last year, while for Dec 2017 it was 159.38%, marking a year-over-year decrease of 23476400.0%. This contributed to the annual value of 199.86% for FY2021, which is 172000.0% up from last year.
  • Bone Biologics' EBT Margin amounted to 189.83% in Q4 2017.
  • Bone Biologics' 5-year EBT Margin high stood at 3954.41% for Q1 2016, and its period low was 106.36% during Q2 2017.